vs
Side-by-side financial comparison of Marti Technologies, Inc. (MRT) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.
Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $14.6M, roughly 1.2× Marti Technologies, Inc.). On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 63.1%).
The Marti Group is a Swiss construction company, consisting of over 80 subsidiaries, officially owned by Marti Holding AG. Besides Switzerland, they are active in neighboring countries such as Germany and Austria, and also outside of Europe such as China and Chile. The company is known for high-profile public and private sector projects and using innovative technologies. Their areas of expertise include building construction, construction and renovation of tunnels, road construction, hydrauli...
Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.
MRT vs SLGL — Head-to-Head
Income Statement — Q2 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $17.3M |
| Net Profit | — | $11.6M |
| Gross Margin | 49.4% | — |
| Operating Margin | -86.1% | 65.1% |
| Net Margin | — | 67.3% |
| Revenue YoY | 63.1% | 217.7% |
| Net Profit YoY | — | 487.6% |
| EPS (diluted) | $-0.26 | $4.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $14.6M | $17.3M | ||
| Q2 24 | $8.9M | $5.4M | ||
| Q2 23 | — | $594.0K | ||
| Q2 22 | — | $3.5M |
| Q2 25 | — | $11.6M | ||
| Q2 24 | — | $2.0M | ||
| Q2 23 | — | $-6.0M | ||
| Q2 22 | — | $-134.0K |
| Q2 25 | 49.4% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q2 25 | -86.1% | 65.1% | ||
| Q2 24 | -204.1% | 29.9% | ||
| Q2 23 | — | -1098.8% | ||
| Q2 22 | — | -13.2% |
| Q2 25 | — | 67.3% | ||
| Q2 24 | — | 36.4% | ||
| Q2 23 | — | -1005.1% | ||
| Q2 22 | — | -3.8% |
| Q2 25 | $-0.26 | $4.17 | ||
| Q2 24 | $-0.38 | $0.71 | ||
| Q2 23 | — | $-0.22 | ||
| Q2 22 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $24.3M |
| Total DebtLower is stronger | $83.0M | — |
| Stockholders' EquityBook value | $-73.2M | $31.9M |
| Total Assets | $17.2M | $39.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $4.2M | $24.3M | ||
| Q2 24 | $9.0M | $26.5M | ||
| Q2 23 | — | $33.5M | ||
| Q2 22 | — | $15.6M |
| Q2 25 | $83.0M | — | ||
| Q2 24 | $60.2M | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q2 25 | $-73.2M | $31.9M | ||
| Q2 24 | $-51.2M | $34.9M | ||
| Q2 23 | — | $48.3M | ||
| Q2 22 | — | $50.4M |
| Q2 25 | $17.2M | $39.3M | ||
| Q2 24 | $25.0M | $42.0M | ||
| Q2 23 | — | $55.1M | ||
| Q2 22 | — | $55.0M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
